Drug Type Cell therapy |
Synonyms- |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization MUVON Therapeutics AGStartup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urinary Incontinence, Stress | Phase 2 | CH | MUVON Therapeutics AGStartup | 01 Sep 2022 |
Urinary Incontinence, Stress | Phase 2 | CH | 01 Sep 2022 |